Literature DB >> 31142838

Growth dynamics in naturally progressing chronic lymphocytic leukaemia.

Michaela Gruber1,2,3,4, Ivana Bozic5, Ignaty Leshchiner2, Dimitri Livitz2, Kristen Stevenson6, Laura Rassenti7, Daniel Rosebrock2, Amaro Taylor-Weiner2, Oriol Olive1, Reaha Goyetche1, Stacey M Fernandes1, Jing Sun1, Chip Stewart2, Alicia Wong2, Carrie Cibulskis2, Wandi Zhang1, Johannes G Reiter8, Jeffrey M Gerold8, John G Gribben9, Kanti R Rai10, Michael J Keating11, Jennifer R Brown1,12,13, Donna Neuberg6, Thomas J Kipps7, Martin A Nowak8,14, Gad Getz15,16,17,18, Catherine J Wu19,20,21,22.   

Abstract

How the genomic features of a patient's cancer relate to individual disease kinetics remains poorly understood. Here we used the indolent growth dynamics of chronic lymphocytic leukaemia (CLL) to analyse the growth rates and corresponding genomic patterns of leukaemia cells from 107 patients with CLL, spanning decades-long disease courses. We found that CLL commonly demonstrates not only exponential expansion but also logistic growth, which is sigmoidal and reaches a certain steady-state level. Each growth pattern was associated with marked differences in genetic composition, the pace of disease progression and the extent of clonal evolution. In a subset of patients, whose serial samples underwent next-generation sequencing, we found that dynamic changes in the disease course of CLL were shaped by the genetic events that were already present in the early slow-growing stages. Finally, by analysing the growth rates of subclones compared with their parental clones, we quantified the growth advantage conferred by putative CLL drivers in vivo.

Entities:  

Mesh:

Year:  2019        PMID: 31142838      PMCID: PMC6630176          DOI: 10.1038/s41586-019-1252-x

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  29 in total

Review 1.  The model muddle: in search of tumor growth laws.

Authors:  Philip Gerlee
Journal:  Cancer Res       Date:  2013-02-07       Impact factor: 12.701

2.  Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse.

Authors:  E Braggio; N E Kay; S VanWier; R C Tschumper; S Smoley; J E Eckel-Passow; T Sassoon; M Barrett; D L Van Dyke; J C Byrd; D F Jelinek; T D Shanafelt; R Fonseca
Journal:  Leukemia       Date:  2012-01-20       Impact factor: 11.528

3.  Genomic aberrations and survival in chronic lymphocytic leukemia.

Authors:  H Döhner; S Stilgenbauer; A Benner; E Leupolt; A Kröber; L Bullinger; K Döhner; M Bentz; P Lichter
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

4.  SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.

Authors:  Lili Wang; Michael S Lawrence; Youzhong Wan; Petar Stojanov; Carrie Sougnez; Kristen Stevenson; Lillian Werner; Andrey Sivachenko; David S DeLuca; Li Zhang; Wandi Zhang; Alexander R Vartanov; Stacey M Fernandes; Natalie R Goldstein; Eric G Folco; Kristian Cibulskis; Bethany Tesar; Quinlan L Sievers; Erica Shefler; Stacey Gabriel; Nir Hacohen; Robin Reed; Matthew Meyerson; Todd R Golub; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  N Engl J Med       Date:  2011-12-12       Impact factor: 91.245

5.  Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.

Authors:  J Ojha; C Secreto; K Rabe; J Ayres-Silva; R Tschumper; D V Dyke; S Slager; R Fonseca; T Shanafelt; N Kay; E Braggio
Journal:  Leukemia       Date:  2014-07-18       Impact factor: 11.528

6.  Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.

Authors:  Anna Schuh; Jennifer Becq; Sean Humphray; Adrian Alexa; Adam Burns; Ruth Clifford; Stephan M Feller; Russell Grocock; Shirley Henderson; Irina Khrebtukova; Zoya Kingsbury; Shujun Luo; David McBride; Lisa Murray; Toshi Menju; Adele Timbs; Mark Ross; Jenny Taylor; David Bentley
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

7.  Mutations driving CLL and their evolution in progression and relapse.

Authors:  Dan A Landau; Eugen Tausch; Amaro N Taylor-Weiner; Chip Stewart; Johannes G Reiter; Jasmin Bahlo; Sandra Kluth; Ivana Bozic; Mike Lawrence; Sebastian Böttcher; Scott L Carter; Kristian Cibulskis; Daniel Mertens; Carrie L Sougnez; Mara Rosenberg; Julian M Hess; Jennifer Edelmann; Sabrina Kless; Michael Kneba; Matthias Ritgen; Anna Fink; Kirsten Fischer; Stacey Gabriel; Eric S Lander; Martin A Nowak; Hartmut Döhner; Michael Hallek; Donna Neuberg; Gad Getz; Stephan Stilgenbauer; Catherine J Wu
Journal:  Nature       Date:  2015-10-14       Impact factor: 49.962

8.  Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease.

Authors:  M J J Rose-Zerilli; J Gibson; J Wang; W Tapper; Z Davis; H Parker; M Larrayoz; H McCarthy; R Walewska; J Forster; A Gardiner; A J Steele; C Chelala; S Ennis; A Collins; C C Oakes; D G Oscier; J C Strefford
Journal:  Leukemia       Date:  2016-02-05       Impact factor: 11.528

9.  Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution.

Authors:  Ivana Bozic; Jeffrey M Gerold; Martin A Nowak
Journal:  PLoS Comput Biol       Date:  2016-02-01       Impact factor: 4.475

10.  Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.

Authors:  S Barrio; T D Shanafelt; J Ojha; K G Chaffee; C Secreto; K M Kortüm; S Pathangey; D L Van-Dyke; S L Slager; R Fonseca; N E Kay; E Braggio
Journal:  Leukemia       Date:  2016-06-14       Impact factor: 11.528

View more
  31 in total

Review 1.  Characterizing the ecological and evolutionary dynamics of cancer.

Authors:  Nastaran Zahir; Ruping Sun; Daniel Gallahan; Robert A Gatenby; Christina Curtis
Journal:  Nat Genet       Date:  2020-07-27       Impact factor: 38.330

2.  Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients.

Authors:  Tycho Baumann; Riccardo Moia; Gianluca Gaidano; Julio Delgado; Adalgisa Condoluci; Neus Villamor; Anil Babu Payedimarri; Dolors Costa; Andrea Patriarca; Carlos Jiménez-Vicente; Davide Rossi; Emili Montserrat
Journal:  Leukemia       Date:  2021-02-04       Impact factor: 11.528

3.  Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies.

Authors:  Julio Delgado; Ferran Nadeu; Dolors Colomer; Elias Campo
Journal:  Haematologica       Date:  2020-07-02       Impact factor: 9.941

4.  Clonal dynamics in chronic lymphocytic leukemia.

Authors:  Catherine Gutierrez; Catherine J Wu
Journal:  Blood Adv       Date:  2019-11-26

Review 5.  Clonal dynamics in chronic lymphocytic leukemia.

Authors:  Catherine Gutierrez; Catherine J Wu
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 6.  Delineating the evolutionary dynamics of cancer from theory to reality.

Authors:  Ivana Bozic; Catherine J Wu
Journal:  Nat Cancer       Date:  2020-06-22

7.  Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy.

Authors:  Anat Biran; Noelia Purroy; Camilla K Lemvigh; Kendell Clement; Michaela Gruber; Catherine J Wu; Alexander Meissner; Helene Kretzmer; Hongcang Gu; Laura Rassenti; Arman W Mohammad; Connie Lesnick; Susan L Slager; Esteban Braggio; Tait D Shanafelt; Neil E Kay; Stacey M Fernandes; Jennifer R Brown; Lili Wang; Shuqiang Li; Kenneth J Livak; Donna S Neuberg; Sven Klages; Bernd Timmermann; Thomas J Kipps; Elias Campo; Andreas Gnirke
Journal:  Blood Cancer Discov       Date:  2020-12-03

Review 8.  Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics.

Authors:  Anna S Nam; Ronan Chaligne; Dan A Landau
Journal:  Nat Rev Genet       Date:  2020-08-17       Impact factor: 53.242

Review 9.  Leveraging Single-Cell Approaches in Cancer Precision Medicine.

Authors:  Aritro Nath; Andrea H Bild
Journal:  Trends Cancer       Date:  2021-02-06

Review 10.  The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment.

Authors:  Claudia Pérez-Carretero; Isabel González-Gascón-Y-Marín; Ana E Rodríguez-Vicente; Miguel Quijada-Álamo; José-Ángel Hernández-Rivas; María Hernández-Sánchez; Jesús María Hernández-Rivas
Journal:  Diagnostics (Basel)       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.